IFRS 15 Revenue for the Pharmaceutical sector
IFRS 15 Revenue for the Pharmaceutical sector
IFRS 15 will change the way many pharma companies account for sales contracts.
IFRS 15 will change the way many pharma companies account for sales contracts. To help you drive your implementation project to the finish line, we鈥檝e pulled together a list of key considerations that many pharma companies need to focus on.
漏 2025 乐鱼（Leyu）体育官网 乐鱼（Leyu）体育官网 Advisors Single Member S.A., a Greece Corporation and a member firm of the 乐鱼（Leyu）体育官网 network of independent member firms affiliated with 乐鱼（Leyu）体育官网 International Cooperative (鈥溊钟悖↙eyu）体育官网 International鈥�), a Swiss entity. All rights reserved.
乐鱼（Leyu）体育官网 International Cooperative (鈥溊钟悖↙eyu）体育官网 International鈥�) is a Swiss entity. Member firms of the 乐鱼（Leyu）体育官网 network of independent firms are affiliated with 乐鱼（Leyu）体育官网 International. 乐鱼（Leyu）体育官网 International provides no client services. No member firm has any authority to obligate or bind 乐鱼（Leyu）体育官网 International or any other member firm vis-脿-vis third parties, nor does 乐鱼（Leyu）体育官网 International have any such authority to obligate or bind any member firm.